Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma

doi:10.4252/wjsc.v10.i11.172

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7647)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

550

WORD

194

HTML

4499

Figures (1-2)

159

Tables (1-2)

201

Sum=5603

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1100

Download

944

Sum=2044

Nov 26, 2018 (publication date) through Apr 15, 2024

Times Cited of This Article

Times Cited (34)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Stem Cells. Nov 26, 2018; 10(11): 172-182
Published online Nov 26, 2018. doi: 10.4252/wjsc.v10.i11.172

Table 2 Deregulated pathways and proteins to target pancreatic cancer stem cells

Deregulated pathways	Compound or strategy	Ref.
Hedgehog	Crocetinic acid	[55]
	Sanguinarine	[56]
	GANT61	[57]
Notch	RO4929097, shRNA	[58]
Notch	Quinomycin A	[59,97,98]
mTOR	Rapamycin	[60]
mTOR	AZD8055	[61]
Deregulated proteins	Compound or strategy
FASN	Cerulenin	[7]
AnxA1	siRNA	[64]
MARCKS	MANS peptide	[66]
Galectin-3	Polysaccharide RN1	[70]
PKM2	Lapachol	[72]
PKM2	Diallyl disulphide	[73]
ERRγ	GSK5182	[82,83]

shRNA: Short hairpin RNA; siRNA: Small interfering RNA; FASN: Fatty acid synthase; mTOR: Mammalian target of rapamycin; AnxA1: Annexin A1; MARCKS: Myristoylated alanine-rich C-kinase substrate; PKM2: Pyruvate kinase isozyme M2.

Citation: Di Carlo C, Brandi J, Cecconi D. Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma. World J Stem Cells 2018; 10(11): 172-182
URL: https://www.wjgnet.com/1948-0210/full/v10/i11/172.htm
DOI: https://dx.doi.org/10.4252/wjsc.v10.i11.172